Corresponding Author: Bradley F. Boeve, MD, Division of Behavioral Neurology, Department of Neurology, Mayo Clinic, 200 First St SW, Rochester, MN 55905 (bboeve@mayo.edu).
Published Online: January 14, 2021. doi:10.1001/jama.2020.15085
Author Contributions: Dr Choudhury and Dr Ramanan contributed equally to this article.
Conflict of Interest Disclosures: Dr Boeve reported grants from Biogen, Alector, EIP Pharma, and personal fees from Rainwater Charitable Foundation outside the submitted work. No other disclosures were reported.
Additional Contributions: We thank the patient for granting permission to publish this information.
2.Elias-Sonnenschein
LS , Viechtbauer
W , Ramakers
IH , Verhey
FR , Visser
PJ . Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis.
J Neurol Neurosurg Psychiatry. 2011;82(10):1149-1156. doi:
10.1136/jnnp.2010.231555PubMedGoogle ScholarCrossref 4.Naj
AC , Jun
G , Reitz
C ,
et al; Alzheimer Disease Genetics Consortium. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.
JAMA Neurol. 2014;71(11):1394-1404. doi:
10.1001/jamaneurol.2014.1491PubMedGoogle ScholarCrossref 7.Rabinovici
GD , Gatsonis
C , Apgar
C ,
et al. Association of amyloid positron emission tomography with subsequent change in clinical management among Medicare beneficiaries with mild cognitive impairment or dementia.
JAMA. 2019;321(13):1286-1294. doi:
10.1001/jama.2019.2000PubMedGoogle ScholarCrossref